Molecular Partners Ag -adr(MOLN)
$5.51▲2.1%
Market is closed - opens 8 PM, 04 Dec 2024
Insights
- Molecular Partners Ag -adr is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Molecular Partners Ag -adr stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Molecular Partners Ag -adr stock is Range bound.
- Based on analysis of the Pivot Points, the current market trend for Molecular Partners Ag -adr stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 46.72 | Neutral |
Stochastic | 28.03, 52.55 | Neutral |
Ultimate Oscillator | 37.47 | Neutral |
Stochastic Relative Strength Index | 69.48, 70.83 | Neutral |
Moving Average Convergence Divergence | -0.02, -0.01 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 5.55 | Sell |
20 | 5.67 | Buy |
50 | 5.44 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 5.59 | Sell |
20 | 5.62 | Sell |
50 | 5.65 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 5.53 | Neutral |
20 | 5.6 | Neutral |
50 | 6.0 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 5.57 | Sell |
20 | 5.6 | Buy |
50 | 5.53 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 5.6 | Buy |
20 | 5.55 | Sell |
50 | 5.64 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 5.9 |
Resistance L2 | 5.88 |
Resistance L1 | 5.85 |
Pivot Point | 5.84 |
Support L1 | 5.8 |
Support L2 | 5.79 |
Support L3 | 5.76 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.